eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
vol. 29
Poleć ten artykuł:
streszczenie artykułu:
Artykuł oryginalny

Ocena postępowania u dzieci i młodzieży z wrodzonym przerostem nadnerczy zgodnie z najnowszymi wytycznymi Towarzystwa Endokrynologicznego

Lalitha Rajalakshmi S.
Hemchand Krishna Prasad
Bharath Ramjee
Lakshmi Venugopalan
Nandhini Ganapathy
Balamourougane Paramasamy

Department of Pediatrics, Mehta Multispeciality Hospitals India Pvt Ltd, India
Department of Pediatric Endocrinology, Mehta Multispeciality Hospitals India Pvt Ltd, India
Department of Endocrinology, Mehta Multispeciality Hospitals India Pvt Ltd, India
Department of Neonatology, Mehta Multispeciality Hospitals India Pvt Ltd, India
Department of Pediatric Surgery, Mehta Multispeciality Hospitals India Pvt Ltd, India
Pediatr Endocrinol Diabetes Metab 2023; 29 (1): 10-15
Data publikacji online: 2022/12/21
Pełna treść artykułu Pobierz cytowanie
Metryki PlumX:

In view of the modifications in the endocrine society guidelines on evaluation and management of children with congenital adrenal hyperplasia (CAH), we performed a review of children and adolescents with CAH.

Material and methods
An audit of 35 children with CAH presenting to the pediatric endocrinology clinic between January 2014 to November 2021 was conducted by formulating ten audit questions. The areas of focus included: genital reconstructive surgery, neonatal screening for CAH, stress dosing, need for adrenocorticotrophic hormone (ACTH) stimulation test, growth promoting therapy, bone age assessment, adrenal imaging, bone mineral density assessment, adequacy of hormone replacement and appropriate management of non-classical CAH.

Conservative approach to genitoplasty in female children increased from 42.9% to 88.9%. Newborn screening identified 4 babies including two asymptomatic males averting saltwasting crisis. Stress dosing of steroids were advised in all and emergency usage of injectable glucocorticoids was warranted in two children. Gonadotropin-releasing hormone (GnRH) analogue therapy improved the final median predicted height by 7 cm in 5 children. Twenty-three (65.7%) had bone age assessment with 14 (40%) having advanced bone age. ACTH stimulation test, Adrenal imaging, dual energy X-ray absorptiometry (DEXA) scan were done in accordance with the guideline. One child with nonclassical CAH was initiated on hydrocortisone replacement for advanced bone age.

A shift to conservative surgical management of females, utility of neonatal screening for CAH, judicious use of growth promoting therapy is highlighted. Need for bone age testing, emergency hydrocortisone provision is warranted in our series.

facebook linkedin twitter
© 2023 Termedia Sp. z o.o.
Developed by Bentus.